Skip Nav Destination
Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study
Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
Issue Archive
May 12 2016
Table of Contents
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
BLOOD SPOTLIGHT
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study
Clinical Trials & Observations
Andreas Tiede,Christoph J. Hofbauer,Sonja Werwitzke,Paul Knöbl,Saskia Gottstein,Rüdiger E. Scharf,Jürgen Heinz,Jürgen Groß,Katharina Holstein,Christiane Dobbelstein,Fritz Scheiflinger,Armin Koch,Birgit M. Reipert
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin
Brief Report
Na Man,Xiao-Jian Sun,Yurong Tan,Marta García-Cao,Fan Liu,Guoyan Cheng,Megan Hatlen,Haiming Xu,Ronit Shah,Nolan Chastain,Na Liu,Gang Huang,Yuan Zhou,Mengyao Sheng,Junhong Song,Feng-Chun Yang,Robert Benezra,Stephen D. Nimer,Lan Wang
RED CELLS, IRON, AND ERYTHROPOIESIS
Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
Antonella Nai,Aude Rubio,Alessandro Campanella,Ophélie Gourbeyre,Irene Artuso,Jessica Bordini,Aurélie Gineste,Chloé Latour,Céline Besson-Fournier,Herbert Y. Lin,Hélène Coppin,Marie-Paule Roth,Clara Camaschella,Laura Silvestri,Delphine Meynard
THROMBOSIS AND HEMOSTASIS
ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice
Frederik Denorme,Friederike Langhauser,Linda Desender,Aline Vandenbulcke,Hanspeter Rottensteiner,Barbara Plaimauer,Olivier François,Tommy Andersson,Hans Deckmyn,Friedrich Scheiflinger,Christoph Kleinschnitz,Karen Vanhoorelbeke,Simon F. De Meyer
TRANSPLANTATION
LETTERS TO BLOOD
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Clinical Trials & Observations
Nikoletta Lendvai,Andrew J. Yee,Ioanna Tsakos,Aeri Alexander,Sean M. Devlin,Hani Hassoun,Neha Korde,Alexander M. Lesokhin,Heather Landau,Sham Mailankody,Guenther Koehne,David J. Chung,Ola Landgren,Noopur S. Raje,Sergio Giralt
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
Clinical Trials & Observations
BLOOD WORK
-
Cover Image
Cover Image
![issue cover]()
Histological analysis of occluding cerebral thrombi retrieved from stroke patients reveal variable composition patterns. A Martius Scarlet Blue staining of a red blood cell–rich thrombus is shown. Red areas indicate the presence of fibrin whereas red blood cells appear yellow. See the article by Denorme et al on page 2337.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
